Trials / Completed
CompletedNCT01168622
Impact of Race/Ethnicity on Platelet Function
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 625 (estimated)
- Sponsor
- University of Nebraska · Academic / Other
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Accepted
Summary
The effects of race/ethnicity on platelet function and response to antiplatelet agents will be assessed using healthy participants and coronary heart disease patients from at least 5 racial/ethnic groups.
Detailed description
The effects of race/ethnicity on platelet function and response to antiplatelet agents will be assessed using 125 healthy subjects, 250 coronary heart disease patients treated with aspirin, and 250 coronary heart disease patients treated with aspirin and a P2Y12 receptor antagonist, clopidogrel or prasugrel. A minimum of 25 healthy people, 50 people taking only aspirin, and 50 people taking aspirin and clopidogrel/prasugrel will be recruited for at least 5 racial/ethnic groups.
Conditions
Timeline
- Start date
- 2010-06-01
- Primary completion
- 2013-03-30
- Completion
- 2013-03-30
- First posted
- 2010-07-23
- Last updated
- 2023-09-01
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01168622. Inclusion in this directory is not an endorsement.